Levodopa‐Responsive Dystonia Secondary to CTNNB1 Neurodevelopmental Disorder
Open Access
- 17 June 2025
- journal article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (11) , 2012-2014
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Movement disorder phenotype in CTNNB1-syndrome: A complex but recognizable phenomenologyParkinsonism & Related Disorders, 2024
- Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorderClinical Genetics, 2024
- CTNNB1 in neurodevelopmental disordersFrontiers in Psychiatry, 2023
- Correlation between Phenotype and Genotype in CTNNB1 Syndrome: A Systematic Review of the LiteratureInternational Journal of Molecular Sciences, 2022
- Minimum Clinically Important Difference of Gross Motor Function and Gait Endurance in Children with Motor Impairment: A Comparison of Distribution‐Based ApproachesBioMed Research International, 2020
- Rationale for dopa‐responsive CTNNB1/ß‐catenin deficient dystoniaMovement Disorders, 2018
- Multiple roles of β-catenin in controlling the neurogenic niche for midbrain dopamine neuronsDevelopment, 2009
- Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalonDevelopment, 2008
- A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivoDevelopment, 2006
- GeneReviews®1993